Stock Screener · Library
Vor Biopharma Inc. financial statement history
Source-linked financial facts for Vor Biopharma Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 242590000 | USD | 2023-03-23 | 2022 / FY | us-gaap:Assets | 10-K · 0000950170-23-009472 |
| As of 2022-12-31 | 299366000 | USD | 2024-03-20 | 2023 / FY | us-gaap:Assets | 10-K · 0000950170-24-034146 |
| As of 2023-12-31 | 198126000 | USD | 2025-03-20 | 2024 / FY | us-gaap:Assets | 10-K · 0000950170-25-042623 |
| As of 2024-12-31 | 142891000 | USD | 2026-03-30 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-130451 |
| As of 2025-12-31 | 464126000 | USD | 2026-03-30 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-130451 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 214399000 | USD | 2023-03-23 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-23-009472 |
| As of 2022-12-31 | 236950000 | USD | 2024-03-20 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-24-034146 |
| As of 2023-12-31 | 140803000 | USD | 2025-03-20 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-25-042623 |
| As of 2024-12-31 | 96507000 | USD | 2026-03-30 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-130451 |
| As of 2025-12-31 | 458105000 | USD | 2026-03-30 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-130451 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 119801000 | USD | 2023-03-23 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-23-009472 |
| As of 2022-12-31 | 57706000 | USD | 2024-03-20 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-24-034146 |
| As of 2023-12-31 | 31360000 | USD | 2025-03-20 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-25-042623 |
| As of 2024-12-31 | 81949000 | USD | 2026-03-30 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-130451 |
| As of 2025-12-31 | 396486000 | USD | 2026-03-30 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-130451 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 6853000 | USD | 2023-03-23 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-23-009472 |
| As of 2022-12-31 | 12634000 | USD | 2024-03-20 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-24-034146 |
| As of 2023-12-31 | 10050000 | USD | 2025-03-20 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-25-042623 |
| As of 2024-12-31 | 6581000 | USD | 2026-03-30 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-130451 |
| As of 2025-12-31 | 533000 | USD | 2026-03-30 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-130451 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 26327000 | USD | 2023-03-23 | 2022 / FY | us-gaap:Liabilities | 10-K · 0000950170-23-009472 |
| As of 2022-12-31 | 48759000 | USD | 2024-03-20 | 2023 / FY | us-gaap:Liabilities | 10-K · 0000950170-24-034146 |
| As of 2023-12-31 | 47402000 | USD | 2025-03-20 | 2024 / FY | us-gaap:Liabilities | 10-K · 0000950170-25-042623 |
| As of 2024-12-31 | 46227000 | USD | 2026-03-30 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-130451 |
| As of 2025-12-31 | 628438000 | USD | 2026-03-30 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-130451 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 10153000 | USD | 2023-03-23 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-23-009472 |
| As of 2022-12-31 | 13119000 | USD | 2024-03-20 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-24-034146 |
| As of 2023-12-31 | 15572000 | USD | 2025-03-20 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-25-042623 |
| As of 2024-12-31 | 18612000 | USD | 2026-03-30 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-130451 |
| As of 2025-12-31 | 25171000 | USD | 2026-03-30 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-130451 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 216263000 | USD | 2024-03-20 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-24-034146 |
| As of 2022-12-31 | 250607000 | USD | 2025-03-20 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-25-042623 |
| As of 2023-12-31 | 150724000 | USD | 2026-03-30 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-130451 |
| As of 2024-12-31 | 96664000 | USD | 2026-03-30 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-130451 |
| As of 2025-12-31 | -164312000 | USD | 2026-03-30 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-130451 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 47529000 | USD | 2023-03-23 | 2022 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-23-009472 |
| 2022-01-01 to 2022-12-31 | 64550000 | USD | 2024-03-20 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-24-034146 |
| 2023-01-01 to 2023-12-31 | 94315000 | USD | 2025-03-20 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-25-042623 |
| 2024-01-01 to 2024-12-31 | 93310000 | USD | 2026-03-30 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-130451 |
| 2025-01-01 to 2025-12-31 | 321532000 | USD | 2026-03-30 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-130451 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -69018000 | USD | 2023-03-23 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-23-009472 |
| 2022-01-01 to 2022-12-31 | -93418000 | USD | 2024-03-20 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-24-034146 |
| 2023-01-01 to 2023-12-31 | -126036000 | USD | 2025-03-20 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-25-042623 |
| 2024-01-01 to 2024-12-31 | -121185000 | USD | 2026-03-30 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-130451 |
| 2025-01-01 to 2025-12-31 | -371642000 | USD | 2026-03-30 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-130451 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -68899000 | USD | 2023-03-23 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-23-009472 |
| 2022-01-01 to 2022-12-31 | -92094000 | USD | 2024-03-20 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-24-034146 |
| 2023-01-01 to 2023-12-31 | -117863000 | USD | 2025-03-20 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-25-042623 |
| 2024-01-01 to 2024-12-31 | -116914000 | USD | 2026-03-30 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-130451 |
| 2025-01-01 to 2025-12-31 | -695981000 | USD | 2026-03-30 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-130451 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -2.1 | USD/shares | 2023-03-23 | 2022 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-23-009472 |
| 2022-01-01 to 2022-12-31 | -2.33 | USD/shares | 2024-03-20 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-24-034146 |
| 2023-01-01 to 2023-12-31 | -1.75 | USD/shares | 2025-03-20 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-25-042623 |
| 2024-01-01 to 2024-12-31 | -34.03 | USD/shares | 2026-03-30 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001193125-26-130451 |
| 2025-01-01 to 2025-12-31 | -70.5 | USD/shares | 2026-03-30 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001193125-26-130451 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -69144000 | USD | 2023-03-23 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-23-009472 |
| 2022-01-01 to 2022-12-31 | -85144000 | USD | 2024-03-20 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-24-034146 |
| 2023-01-01 to 2023-12-31 | -100292000 | USD | 2025-03-20 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-25-042623 |
| 2024-01-01 to 2024-12-31 | -99660000 | USD | 2026-03-30 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-130451 |
| 2025-01-01 to 2025-12-31 | -142713000 | USD | 2026-03-30 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-130451 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 3894000 | USD | 2023-03-23 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-23-009472 |
| 2022-01-01 to 2022-12-31 | 8462000 | USD | 2024-03-20 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-24-034146 |
| 2023-01-01 to 2023-12-31 | 1069000 | USD | 2025-03-20 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-25-042623 |
| 2024-01-01 to 2024-12-31 | 229000 | USD | 2026-03-30 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001193125-26-130451 |
| 2025-01-01 to 2025-12-31 | 941000 | USD | 2026-03-30 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001193125-26-130451 |
Dividends paid
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 0 | USD | 2023-03-23 | 2022 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0000950170-23-009472 |
| 2022-01-01 to 2022-12-31 | 0 | USD | 2024-03-20 | 2023 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0000950170-24-034146 |
| 2023-01-01 to 2023-12-31 | 0 | USD | 2025-03-20 | 2024 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0000950170-25-042623 |
| 2024-01-01 to 2024-12-31 | 0 | USD | 2026-03-30 | 2025 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0001193125-26-130451 |
| 2025-01-01 to 2025-12-31 | 0 | USD | 2026-03-30 | 2025 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0001193125-26-130451 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1817229
- Ticker in native snapshot
- VOR
- Reported numeric facts
- 70
- Units present
- USD · USD/shares